SCHEMBL7248928

SCHEMBL7248928

O=C1/C(=C/c2ccccc2)SC(c2cccc(F)c2)N1CCCN1CCN(c2ccccn2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 8/20 0.49
DRD2 P14416 10/20 0.44
DRD3 P35462 9/20 0.44
HTR1A P08908 7/20 0.44
HTR2A P28223 7/20 0.44
DRD4 P21917 7/20 0.44
ADRA2C P18825 3/20 0.44
DRD1 P21728 3/20 0.44
DRD5 P21918 3/20 0.44
HRH1 P35367 3/20 0.44
SLC6A4 P31645 2/20 0.44
SIGMAR1 Q99720 4/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
LMNA P02545 1/20 0.44
CYP2D6 P10635 1/20 0.44
HTR2C P28335 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7248930 1.00 HTR7 (0.49) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7254858 0.97 HTR7 (0.49) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7254856 0.97 HTR7 (0.49) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7250578 0.94 HTR7 (0.47) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7250581 0.94 HTR7 (0.47) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7254177 0.91 HTR7 (0.46) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7254175 0.91 HTR7 (0.46) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7248265 0.90 DRD4 (0.47) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7248267 0.90 DRD4 (0.47) HTR7DRD2DRD3HTR1AHTR2A
SCHEMBL7251895 0.89 DRD3 (0.47) HTR7DRD2DRD3HTR1ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US claimed